GlobalDeal

Threshold Pharmaceuticals

Biotechnology · South San Francisco, United States

thresholdpharm.com

About Threshold Pharmaceuticals

Threshold Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing novel therapeutics for the treatment of cancer. The company is known for its innovative approach to targeting the tumor microenvironment, particularly in hypoxic conditions, which are common in solid tumors. Threshold's lead product candidate, TH-302, is designed to selectively deliver a cytotoxic agent to hypoxic tumor cells, thereby enhancing the efficacy of cancer treatment while minimizing damage to normal tissues. The company aims to improve patient outcomes through its research and development efforts, which are supported by a strong pipeline of drug candidates. Threshold Pharmaceuticals is committed to advancing the field of oncology by leveraging its proprietary technology and expertise in drug development.

Company facts

Industry
Biotechnology
Sub-industries
Pharmaceuticals, Oncology, Drug Development
Location
South San Francisco, United States
Employees
1–10
Revenue (USD)
<1M

Products and services

Open Threshold Pharmaceuticals in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in United States

All 17,138 Biotechnology companies in United States →